Shaping Discovery, Improving Life

Life Technologies Foundation

2010 Funding Opportunities

The Life Technologies Foundation™ is dedicated to recognizing the power of each scientist’s contribution to improving the human condition.

By teaming with researchers across countries and cultures, we strive to demystify the world of life science, empower today’s children to become tomorrow’s scientific leaders and deepen society’s appreciation of science and its profound impact on our lives. Local organizations within communities where Life Technologies has a presence are welcome to apply. "Local" is defined as within a 50 mile radius of a Life Technologies owned or leased facility within the United States. Potential applicants should view the PDF application and guideline forms to the right-hand side of this page.

Life Technologies Foundation Logo

Life Technologies Foundation

7305 Executive Way
Frederick, Maryland 21704
U.S.
foundation@lifetech.com

  • Life Technology Foundation Group Photo
  • Life Technology Foundation Lab Photo
  • Life Technology Foundation Event Photo

News

  • SOLiD 4 Announced

    Company announces SOLiD(TM) 4 System, delivering industry's most cost effective, highest quality genome for $6,000, reduced to $3,000 by end of 2010 with SOLiD(TM) 4hq upgrade.

    Read All Close

  • LT & Ignite Institute

    Life Technologies and the Ignite Institute for Individualized Health for a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia. Ignite will acquire 100 of the Applied Biosystems SOLiD(TM) 4 Systems, the most advanced next generation DNA sequencing platform on the market, establishing the largest concentration of genetic analytical power in North America.

    Read All Close

  • Q4 & FY09 Results

    Life Technologies today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

    Read All Close

Life (Common Stock)

© 2010 Life Technologies Corporation. All Rights Reserved